MLNT - Melinta Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $26.1. This is a potential upside of $26.1 (0%) from yesterday's end of day stock price of $0.

Melinta Therapeutics's activity chart (see below) currently has 6 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by DAVID HOANG from SMBC NIKKO on 10-May-2019. First documented stock forecast 11-Sep-2018.

David Hoang Ed Arce

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$2.48 (98.41%)

4 years 11 months 29 days ago

0/1 (0%)

$1.55 (44.93%)

Buy

$62.48 (2479.37%)

5 years 6 months 8 days ago

0/4 (0%)

$50.65 (352.96%)

Show more analysts

What is MLNT (Melinta Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MLNT (Melinta Therapeutics) with a proven track record?

DAVID HOANG

Which analyst has the current lower performing score on MLNT (Melinta Therapeutics) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on MLNT (Melinta Therapeutics)?

David Hoang works at CITI and has 4 price targets and 3 ratings on MLNT

Which analyst is the currently most bullish on MLNT (Melinta Therapeutics)?

Ed Arce with highest potential upside - $62.48

Which analyst is the currently most reserved on MLNT (Melinta Therapeutics)?

David Hoang with lowest potential downside - $2.48